Home Podcasts AudioScholar Pathology Weekly
AudioScholar Pathology Weekly

AudioScholar Pathology Weekly

AudioScholar 10 Episodes Oct 10, 2026

A weekly podcast briefing of the most significant peer-reviewed pathology literature, synthesized from PubMed and delivered as ~10-minute audio for practicing physicians. Generated by AudioScholar.

Episodes

This Week in Pathology — Oct 10, 2026
This Week in Pathology — Oct 10, 2026 Oct 10, 2026 634 This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning a new soft tissue and bone… This week's papers: 1. The 2026 World Health Organization Classification of Tumors of Soft Tissue and Bone: 6th Edition. — The American Journal of
This Week in Pathology — Oct 3, 2026
This Week in Pathology — Oct 3, 2026 Oct 3, 2026 717 This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning predictive biomarker scori… This week's papers: 1. Claudin 18.2 Immunohistochemistry in Gastroesophageal Adenocarcinomas: A Study of Interobserver Variability Among Gastrointe
This Week in Pathology — Sep 26, 2026
This Week in Pathology — Sep 26, 2026 Sep 26, 2026 789 This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning reproducibility and gradin… This week's papers: 1. Inter-rater reliability of frozen donor liver macrovesicular steatosis assessment applying the Banff consensus method: a rea
This Week in Pathology — Sep 19, 2026
This Week in Pathology — Sep 19, 2026 Sep 19, 2026 694 Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning three broad themes: the unglamorous but decisive questions of which stain and which block we choose, transcription-factor and copy-number subtyping of aggressive t… This week's papers: 1. Orcein is a more sensitive stain than EVG for detecting large vessel (venous) invasion in colorectal cancer. — Histopatholog
This Week in Pathology — Sep 12, 2026
This Week in Pathology — Sep 12, 2026 Sep 12, 2026 737 Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning classification and molecular taxonomy, new immunohistochemical markers that solve everyday diagnostic problems, and the recurring challenge of cutaneous and soft t… This week's papers: 1. Gastric carcinoma classification in the WHO 6th edition (2026): Updated framework and emerging entities. — Virchows Archiv 2
This Week in Pathology — Sep 5, 2026
This Week in Pathology — Sep 5, 2026 Sep 5, 2026 654 Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning three broad themes: artificial intelligence and quantification in the laboratory, consensus and standardization efforts that shape how we report, and the molecular… This week's papers: 1. International Society of Urological Pathology Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Ef
This Week in Pathology — Aug 30, 2026
This Week in Pathology — Aug 30, 2026 Aug 30, 2026 689 Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning molecular biomarker interpretation and its reproducibility, classification updates in soft tissue, skin and gastrointestinal pathology, and the recurring theme of… This week's papers: 1. Liquid biopsy in solid tumours: expert opinion paper of the European society of pathology — Virchows Archiv 2026 2. Cutaneous
This Week in Pathology — Aug 23, 2026
This Week in Pathology — Aug 23, 2026 Aug 23, 2026 609 Welcome to This Week in Pathology. This week we're covering ten notable papers spanning predictive biomarker testing in gastrointestinal and gynaecological cancers, the diagnostic pitfalls of immunohistochemistry when a single stain is asked to do to… This week's papers: 1. Pancreatic ductal adenocarcinoma and its subtypes: clinical relevance of histopathology and molecular characterization, inte
This Week in Pathology — Aug 16, 2026
This Week in Pathology — Aug 16, 2026 Aug 16, 2026 777 Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning smarter test-triage strategies that replace expensive downstream assays, the persistent problem of interobserver variability and what artificial intelligence is ac… This week's papers: 1. Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes: A Large Cohort Study — Mode
This Week in Pathology — Aug 9, 2026
This Week in Pathology — Aug 9, 2026 Aug 9, 2026 682 Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning diagnostic criteria and classification challenges, the expanding role of genomic and molecular profiling in tissue and cytology specimens, and the limits of artifi… This week's papers: 1. Evidence for non-mucinous pulmonary lesions with adenocarcinoma in situ morphology exceeding the current 3 cm WHO threshold.
This Week in Pathology — Aug 2, 2026
This Week in Pathology — Aug 2, 2026 Aug 2, 2026 791 Welcome to This Week in Pathology. This week we're covering 10 notable papers spanning diagnostic mimics that can send a case down the wrong treatment pathway, molecular refinement of familiar tumour families in thyroid, bone and soft tissue, and the… This week's papers: 1. Sporadic Burkitt Lymphoma Lacking MYC Protein Expression: A Rare Entity With Diagnostic Pitfalls and Dismal Prognosis — The
This Week in Pathology — Jul 26, 2026
This Week in Pathology — Jul 26, 2026 Jul 26, 2026 521 Welcome to This Week in Pathology. This week we're covering 8 notable papers spanning genitourinary oncology diagnostics, molecular pathology of gastrointestinal and breast cancers, and artificial intelligence applications in anatomic pathology. Let'… This week's papers: 1. Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer. — The New England journal of medicine 2026 2. Lim

Recommended